Chemoprevention of human actinic keratoses by topical 2-(Difluoromethyl)-dl-ornithine

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 12, 2000, Pages 1281-1286

  Alberts, D S ^a   Dorr, R T ^a   Einspahr, J G ^a   Aickin, M ^a   Saboda, K ^a   Xu, M J ^a   Peng, Y M ^a   Goldman, R ^a   Foote, J A ^a   Warneke, J A ^a   Salasche, S ^a   Roe, D J ^a   Bowden, G T ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; ORNITHINE DECARBOXYLASE INHIBITOR; PLACEBO; SPERMIDINE;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN BIOPSY; SKIN CARCINOGENESIS; SKIN IRRITATION;

AGED; ANTINEOPLASTIC AGENTS; EFLORNITHINE; ENZYME INHIBITORS; FEMALE; HUMANS; KERATOSIS; MALE; OINTMENTS; PHOTOSENSITIVITY DISORDERS;

EID: 0034523080     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Malignant transformation of solar keratoses to squamous cell carcinoma
2. Precursors to skin cancer
3. An overview of skin cancers. Incidence and causation
4. Changes in skin protection behaviors, attitudes, and sunburn: In a population with the highest incidence of skin cancer in the world
5. Trends in the incidence of non-melanoma skin cancer in the SE Netherlands 1975-1988: A registry-based study
6. Changes in skin cancer morbidity between 1971-72 and 1977-78
7. Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987
8. The emerging epidemic of melanoma and squamous cell skin cancer
9. Descriptive epidemiology of skin cancer in the Swiss Canton of Vaud
10. The Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer
11. Trends in non-melanocytic skin cancer treated in Australia: The second national survey
12. Sunlight, ultraviolet radiation and the skin
13. The epidemic of squamous cell carcinoma
14. Estimating increases in skin cancer morbidity due to increases in ultraviolet radiation exposure
15. Stratospheric ozone depletion
16. Re: "Skin cancer and UV radiation" (Letter)
17. Skin cancer (other than melanoma)
18. Modification of photocarcinogenesis by chemical agents
19. The role of treatment of actinic keratoses in the prevention of morbidity and mortality due to squamous cell carcinoma
20. Management of actinic keratoses with topical 5-fluoro-uracil
21. Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective
22. Inhibition of polyamine metabolism and the consequent effects on cell proliferation
23. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy
24. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: A review
25. Interspecies analysis of the chemopreventive efficacy of dietary α-difluoromethylomithine
26. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by α-difluoromethylornithine
27. Modulation of mouse skin tumor promotion by dietary 13-cis-retinoic acid and α-difluoromethylomithine
28. α-Difluoromethylomithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin
29. Prevention by α-difluoromethylomithine of skin carcinogenesis and immunosuppression induced by ultraviolet irradiation
30. Les polyamines dans le psoriasis
31. The sun penetration cell: A design update
32. Analysis and storage stability of polyamines in human skin
33. A new precolumn derivatization method for determination of α-difluoromethylomithine and ornithine in biological specimens by HPLC
34. Ways of measuring change
35. Evaluation of α-difluoromethylomithine as a potential chemopreventive agent: Tolerance to daily oral administration in humans
36. Randomized phase I chemoprevention dose-seeking study of α-difluoromethylomithine
37. Decreased expression of protooncogenes c-fos, c-myc, and c-jun following polyamine depletion in IEC-6 cells